the paradox is, the better the deal for ADN, in the eyes of the market, the more their scrip becomes worth to MEP holders. The better the deal for MEP, presumably this might drag on the ADN SP, so could end up in a similar or worse outcome. Going to be interesting who thinks who gets the best deal here, but ultimately, the project should remain on track and hopefully this is another major market milestone achieved.
MEP Price at posting:
13.0¢ Sentiment: Hold Disclosure: Held
